Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (271-280 of 524) with videos related to

Pageof 53
Sort By:
Cancer Chemotherapy and Pharmacology|February 19, 2010
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignanciesPaul K Paik, Charles M Rudin, Andrew Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2021
Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung CancerKathryn C Arbour, Hira Rizvi, Andrew J Plodkowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancerJ C Osorio, A Ni, J E Chaft, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief reportPatrick M Forde, Craig M Hooker, Sosipatros A Boikos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancerC M Rudin, J Holmlund, G F Fleming, et al.
Molecular Cancer Research : MCR|November 12, 2009
Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancerJoelle Hillion, Lisa J Wood, Mita Mukherjee, et al.
Cancers|July 12, 2025
Integration of Next Generation Sequencing Data to Inform Survival Prediction of Patients with Spine MetastasisAlexandra Giantini-Larsen, Alexander D Ramos, Axel Martin, et al.
Plos One|March 17, 2015
Hedgehog signaling pathway is active in GBM with GLI1 mRNA expression showing a single continuous distribution rather than discrete high/low clustersVikas Chandra, Tapojyoti Das, Puneet Gulati, et al.
JCO Precision Oncology|September 24, 2025
Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine CarcinomasJessica S Ross, Rohit Thummalapalli, Kristine Lacuna, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 6, 2017
Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiationAbraham J Wu, Andrea Gillis, Amanda Foster, et al.
Pageof 53

Showing results (271-280 of 524) with videos related to

Sort By:
Pageof 53
Cancer Chemotherapy and Pharmacology|February 19, 2010
A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignanciesPaul K Paik, Charles M Rudin, Andrew Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2021
Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C-Mutant Non-Small Cell Lung CancerKathryn C Arbour, Hira Rizvi, Andrew J Plodkowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancerJ C Osorio, A Ni, J E Chaft, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief reportPatrick M Forde, Craig M Hooker, Sosipatros A Boikos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancerC M Rudin, J Holmlund, G F Fleming, et al.
Molecular Cancer Research : MCR|November 12, 2009
Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancerJoelle Hillion, Lisa J Wood, Mita Mukherjee, et al.
Cancers|July 12, 2025
Integration of Next Generation Sequencing Data to Inform Survival Prediction of Patients with Spine MetastasisAlexandra Giantini-Larsen, Alexander D Ramos, Axel Martin, et al.
Plos One|March 17, 2015
Hedgehog signaling pathway is active in GBM with GLI1 mRNA expression showing a single continuous distribution rather than discrete high/low clustersVikas Chandra, Tapojyoti Das, Puneet Gulati, et al.
JCO Precision Oncology|September 24, 2025
Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine CarcinomasJessica S Ross, Rohit Thummalapalli, Kristine Lacuna, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 6, 2017
Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiationAbraham J Wu, Andrea Gillis, Amanda Foster, et al.
Pageof 53